Cybersecurity stocks got a boost on Wednesday as industry stalwart CyberArk (CYBR) reported stronger-than-expected ...

AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced its recognition as a Customers' Choice in the 2024 Gartner (NYSE:IT) Peer Insights™... ByInvesting.com • Jul 11 ...

It's unclear what authority the department would have, but investors are placing bets on companies like Palantir (NYSE: PLTR) ...

CrowdStrike's proactive response to the crisis suggests robust short-to-medium-term growth. Read why CRWD stock may work ...

Palo Alto Networks has made a bold shift to accelerate platformization. Read why it may hurt short term but has excellent ...

November 13, 2024--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to ...

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity ...

PARIS, France, November 13, 2024, 10:00 pm CET – Abivax SA (Euronext Paris and Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that ...

Microsoft-backed (NASDAQ:MSFT) OpenAI appears to be taking advantage of the change in leadership at the White House and Congress as it plans to reveal a policy blueprint regarding artificial ...

Topline data from Phase 2b/3 trial of izokibep as a treatment for non-infectious non-anterior uveitis expected in December 2024 Positive lonigutamab EOP2 FDA interaction completed and initiation of ...

Discontinuing development of istisociclib, a CDK9 inhibitor; benefit-risk profile in platinum-resistant high-grade serous ...